Harvard’s new AI model identifies potential treatments for rare diseases using existing drugs
Recent advancements in biological AI models have shown significant potential in the development of new medications. But can these technologies also be leveraged to find treatments for rare diseases using drugs that are already available? Researchers at Harvard Medical School aimed to explore this possibility with their new foundation model, TxGNN, which is specifically designed to identify...Read Moreby Nicholas FeenieOctober 18, 2024 Medication, Obesity and Population Health, Obesity in the UK, Obesity Policy0 comments
Experts urge NHS to rethink weight loss injection plans
Top experts are urging an immediate review to ensure that individuals in England can access weight loss injections, such as Wegovy and Mounjaro, through the NHS. This follows a statement from the prime minister, who highlighted the potential economic benefits of these treatments by helping individuals living with obesity re-enter the workforce. Over 200 medical professionals and...Read MoreGLP-1 drugs like Ozempic show promise for protecting brain health
The popularity of GLP-1 receptor agonist medications, including Wegovy, Ozempic, and Zepbound, has surged in recent years as many individuals turn to these treatments for managing type 2 diabetes and obesity. While these medications are well-known for their ability to enhance insulin sensitivity and promote weight loss, growing evidence indicates that their benefits may extend beyond these...Read MoreStudy reveals sweet tooth linked to increased risk of depression, diabetes, and stroke
Individuals with a preference for sweet foods and sugary drinks face a significantly higher risk of developing conditions such as depression, diabetes, and stroke, according to groundbreaking research from the University of Surrey. The study, which highlights the complex interplay between dietary habits and long-term health, was recently published in the Journal of Translational Medicine....Read MoreSurge in digital health investment as purchasers focus on value, outcomes, and patient-centred care
The latest survey from the Peterson Health Technology Institute (PHTI) highlights a significant increase in the planned investment in digital health solutions by health plans, employers, and healthcare systems. This upward trend is expected to continue throughout the coming year as these groups prioritise value and measurable outcomes in their purchasing decisions. Detailed Insights from...Read Moreby Nicholas FeenieOctober 14, 2024 Artificial Intelligence, Digital Health, Electronic Patient Records0 comments